共 402 条
[1]
Timp JF(2013)Epidemiology of cancer-associated venous thrombosis Blood 122 1712-1723
[2]
Braekkan SK(2017)Cancer-associated venous thromboembolism: burden, mechanisms, and management Thromb Haemost 117 219-230
[3]
Versteeg HH(2002)Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis Blood 100 3484-3488
[4]
Cannegieter SC(2016)International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer Lancet Oncol 17 e452-e466
[5]
Ay C(2016)Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report Chest 149 315-352
[6]
Pabinger I(2015)Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update J Oncol Pract 11 e442-e444
[7]
Cohen AT(2015)Tinzaparin vs warfarin for treatment of acute venous thromboembolism in patients with active cancer: a randomized clinical trial JAMA 314 677-686
[8]
Prandoni P(2013)Treatment of cancer-associated thrombo-sis Blood 122 2310-2317
[9]
Lensing AW(2015)Venous thromboem-bolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology Clinical Practice guide-line update 2014 J Clin Oncol 33 654-656
[10]
Piccioli A(2016)Spotlight on advances in VTE manage-ment: CALLISTO and EINSTEIN CHOICE Thromb Haemost 116 S24-S32